152 papers found
Refreshing results…
Additional file 4: Figure S3. of Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
Additional file 5: Figure S4. of Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
Frequency and Clinical Implication of SOX11 Expression in Burkitt Lymphoma
The Absolute Number of Extranodal Sites Detected By PET-CT Is a Powerful Predictor of Secondary Central Nervous System Involvement in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
Prognostic Factors for Patients with Diffuse Large B Cell Lymphoma and Transformed Indolent Lymphoma Undergoing Autologous Stem Cell Transplantation in Denmark 2000-2012
Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma: Extranodal disease in PET/CT staged diffuse large B-cell lymphoma
Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study
Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients: PET/CT in Nodal Peripheral T-Cell Lymphomas
Are we ready to predict late effects? A systematic review of clinically useful prediction models
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL
A clinically based prognostic index for diffuse large B-cell lymphoma (DLBCL-PI) with a cut-off at 70 years of age significantly improves prognostic stratification. Population-based analysis from the Danish Lymphoma Registry.
outcome determinats for transformed indolent lymphomas treated with or without autologous stem cell transplantation.
F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
Epigenetic Silencing of Mir-203 Contributes to IL2Rb Overexpression and Malignant Transformation in Cutaneous T-Cell Lymphoma
The Prognostic Value of MYC, BCL2 and BCL6 Translocations and Protein Expressions in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma Treated with R-CHOEP
The Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Demonstrates Broad and Durable Clinical Activity in Relapsed / Refractory Non Hodgkin’s Lymphoma (NHL)
Missing publications? Read more about our data sources.